Gentris last week expanded its genomic biomarker offering to include Affymetrix GeneChip Human Transcriptome Array services.
The HTA is an expression array designed to complement next-generation sequencing-based studies, Gentris said, and is able to detect all known transcript isoforms produced by a gene.
In a statement, Gentris President Amelia Wall-Warner said that the array provides an "opportunity to advance translational medicine by cost-effectively providing insight into global gene expression of transcript isoforms in large clinical studies."